Page last updated: 2024-11-01

nitroglycerin and Experimental Mammary Neoplasms

nitroglycerin has been researched along with Experimental Mammary Neoplasms in 1 studies

Nitroglycerin: A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives.
nitroglycerol : A nitrate ester that is glycerol in which nitro group(s) replace the hydrogen(s) attached to one or more of the hydroxy groups.
nitroglycerin : A nitroglycerol that is glycerol in which the hydrogen atoms of all three hydroxy groups are replaced by nitro groups. It acts as a prodrug, releasing nitric oxide to open blood vessels and so alleviate heart pain.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Leon-Bollotte, L1
Subramaniam, S1
Cauvard, O1
Plenchette-Colas, S1
Paul, C1
Godard, C1
Martinez-Ruiz, A1
Legembre, P1
Jeannin, JF1
Bettaieb, A1

Other Studies

1 other study available for nitroglycerin and Experimental Mammary Neoplasms

ArticleYear
S-nitrosylation of the death receptor fas promotes fas ligand-mediated apoptosis in cancer cells.
    Gastroenterology, 2011, Volume: 140, Issue:7

    Topics: Animals; Apoptosis; Biotinylation; Cell Line, Tumor; Colonic Neoplasms; Cysteine; Fas Ligand Protein

2011